Multi-Organ toxicity demonstration in a functional human in vitro system composed of four organs C Oleaga, C Bernabini, AST Smith, B Srinivasan, M Jackson, W McLamb, ... Scientific reports 6 (1), 20030, 2016 | 437 | 2016 |
How multi-organ microdevices can help foster drug development MB Esch, AST Smith, JM Prot, C Oleaga, JJ Hickman, ML Shuler Advanced drug delivery reviews 69, 158-169, 2014 | 175 | 2014 |
Investigation of the effect of hepatic metabolism on off-target cardiotoxicity in a multi-organ human-on-a-chip system C Oleaga, A Riu, S Rothemund, A Lavado, CW McAleer, CJ Long, ... Biomaterials 182, 176-190, 2018 | 158 | 2018 |
Networking of differentially expressed genes in human cancer cells resistant to methotrexate E Selga, C Oleaga, S Ramírez, MC de Almagro, V Noé, CJ Ciudad Genome medicine 1, 1-16, 2009 | 87 | 2009 |
Long‐term electrical and mechanical function monitoring of a human‐on‐a‐chip system C Oleaga, A Lavado, A Riu, S Rothemund, CA Carmona‐Moran, ... Advanced functional materials 29 (8), 1805792, 2019 | 81 | 2019 |
Microphysiological heart–liver body-on-a-chip system with a skin mimic for evaluating topical drug delivery CPP de Mello, C Carmona-Moran, CW McAleer, J Perez, EA Coln, ... Lab on a Chip 20 (4), 749-759, 2020 | 73 | 2020 |
Self-contained, low-cost Body-on-a-Chip systems for drug development YI Wang, C Oleaga, CJ Long, MB Esch, CW McAleer, PG Miller, ... Experimental biology and medicine 242 (17), 1701-1713, 2017 | 70 | 2017 |
A phenotypic in vitro model for the main determinants of human whole heart function M Stancescu, P Molnar, CW McAleer, W McLamb, CJ Long, C Oleaga, ... Biomaterials 60, 20-30, 2015 | 68 | 2015 |
Role of PAI-1 in hepatic steatosis and dyslipidemia JA Levine, C Oleaga, M Eren, AP Amaral, M Shang, E Lux, SS Khan, ... Scientific reports 11 (1), 430, 2021 | 60 | 2021 |
CYP1A1 is overexpressed upon incubation of breast cancer cells with a polyphenolic cocoa extract C Oleaga, M García, A Solé, CJ Ciudad, M Izquierdo-Pulido, V Noé European Journal of Nutrition 51, 465-476, 2012 | 42 | 2012 |
Identification of novel Sp1 targets involved in proliferation and cancer by functional genomics C Oleaga, S Welten, A Belloc, A Solé, L Rodriguez, N Mencia, E Selga, ... Biochemical pharmacology 84 (12), 1581-1591, 2012 | 40 | 2012 |
Stability and immunogenicity properties of the gene-silencing polypurine reverse Hoogsteen hairpins X Villalobos, L Rodriguez, J Prevot, C Oleaga, CJ Ciudad, V Noe Molecular pharmaceutics 11 (1), 254-264, 2014 | 39 | 2014 |
Enhanced production of Aspergillus tamarii lipase for recovery of fat from tannery fleshings A Dayanandan, S Rani, M Shanmugavel, A Gnanamani, GS Rajakumar Brazilian Journal of Microbiology 44, 1089-1095, 2013 | 35 | 2013 |
The redox state of cytochrome c modulates resistance to methotrexate in human MCF7 breast cancer cells S Barros, N Mencia, L Rodríguez, C Oleaga, C Santos, V Noe, CJ Ciudad PLoS One 8 (5), e63276, 2013 | 28 | 2013 |
Coffee Polyphenols Change the Expression of STAT5B and ATF‐2 Modifying Cyclin D1 Levels in Cancer Cells C Oleaga, CJ Ciudad, V Noe, M Izquierdo-Pulido Oxidative Medicine and Cellular Longevity 2012 (1), 390385, 2012 | 25 | 2012 |
Hepatic sensing loop regulates PCSK9 secretion in response to inhibitory antibodies C Oleaga, MD Shapiro, J Hay, PA Mueller, J Miles, C Huang, E Friz, ... Journal of the American College of Cardiology 78 (14), 1437-1449, 2021 | 22 | 2021 |
Unusual responses to PCSK9 inhibitors in a clinical cohort utilizing a structured follow-up protocol BA Warden, JR Miles, C Oleaga, OP Ganda, PB Duell, JQ Purnell, ... American Journal of Preventive Cardiology 1, 100012, 2020 | 22 | 2020 |
Insights into the kinetics and dynamics of the furin-cleaved form of PCSK9 C Oleaga, J Hay, E Gurcan, LL David, PA Mueller, H Tavori, MD Shapiro, ... Journal of lipid research 62, 2021 | 17 | 2021 |
Ciudad CJ, Izquierdo-Pulido M, Noé V. Cocoa flavanol metabolites activate HNF-3β, Sp1, and NFY-mediated transcription of apolipoprotein AI in human cells C Oleaga Mol. Nutr. Food Res 57, 986-995, 2013 | 16 | 2013 |
Cocoa flavanol metabolites activate HNF‐3β, S p1, and NFY‐mediated transcription of apolipoprotein AI in human cells C Oleaga, CJ Ciudad, M Izquierdo‐Pulido, V Noé Molecular nutrition & food research 57 (6), 986-995, 2013 | 14 | 2013 |